At the 2025 Annual Meeting held on July 24, 2025, Haemonetics Corporation shareholders elected new directors, approved executive compensation, and ratified Ernst & Young as auditors with a quorum of 94.95%. Overall voting saw significant support for director nominations and compensation plans while confirming the accounting firm for the next fiscal year.